These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease. Teipel S; Grothe MJ; J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707 [TBL] [Abstract][Full Text] [Related]
3. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease. Grothe M; Heinsen H; Teipel SJ Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388 [TBL] [Abstract][Full Text] [Related]
6. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601 [TBL] [Abstract][Full Text] [Related]
7. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease? Teipel S; Grothe MJ; Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):526-36. PubMed ID: 26555082 [TBL] [Abstract][Full Text] [Related]
8. Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment. Kilimann I; Hausner L; Fellgiebel A; Filippi M; Würdemann TJ; Heinsen H; Teipel SJ Cereb Cortex; 2017 Mar; 27(3):1841-1848. PubMed ID: 26879092 [TBL] [Abstract][Full Text] [Related]
9. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Cavedo E; Lista S; Houot M; Vergallo A; Grothe MJ; Teipel S; Zetterberg H; Blennow K; Habert MO; Potier MC; Dubois B; Hampel H; ; Alzheimer Precision Medicine Initiative Neurology; 2020 Jan; 94(1):e30-e41. PubMed ID: 31801830 [TBL] [Abstract][Full Text] [Related]
10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
11. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration. Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383 [TBL] [Abstract][Full Text] [Related]
12. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940 [TBL] [Abstract][Full Text] [Related]
13. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619 [TBL] [Abstract][Full Text] [Related]
14. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW; Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697 [TBL] [Abstract][Full Text] [Related]
15. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease. Kljajevic V; Grothe MJ; Ewers M; Teipel S; Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241 [TBL] [Abstract][Full Text] [Related]
16. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease. Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315 [TBL] [Abstract][Full Text] [Related]
17. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease. Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW; J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335 [TBL] [Abstract][Full Text] [Related]
18. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease. Xia Y; Dore V; Fripp J; Bourgeat P; Laws SM; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe C; Masters CL; Coulson EJ; Maruff P Neurology; 2024 Jul; 103(2):e209626. PubMed ID: 38885444 [TBL] [Abstract][Full Text] [Related]
19. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment. Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417 [TBL] [Abstract][Full Text] [Related]